Linda, in the midst of chemo, entertains a
great nephew
Heron Island, Maine, 2009
A tip from Google Alerts to an article by one Maggie Fox
published by NBC News has lured me into a downward spiral into the black depths
of bio-genetics. To get the reference
out of the way:
So, anyway, some people at the National Human Genome
Research Institute, a part of NIH, have been looking for genetic markers that
would reliably predict the presence of cancer in the absence of symptoms – and they
may have found one. They performed what
I believe is called a GWAS – a Genome Wide Association Study – and found
something exciting. Specifically, they
saw that tumors in the colon, breast and stomach, as well as in endometrial
cancer all showed abnormal methylation near a particular gene, ZNF154. Fifteen discrete types of cancer were
involved. Why this unusual methylation
pattern exists is not yet clear, but present results strongly suggest that this
observed association will be valuable for early detection. They are testing it on ovarian cancer at the
present time.
Okay, that’s all you really need to know. However, it you want to follow my doomed
spiral into biochemical oblivion, read on.
First, methylation. A
methyl group is a molecule consisting of three hydrogen atoms bonded to a
central carbon: CH3 in chem-speak.
Methylation itself is the attachment of a methyl group to a specific
spot on the DNA molecule, in order to “regulate” something – usually, shut off
(inactivate) a gene. Methylation is an
important epigenetic process. Read all
about it here:
Now, how about gene ZNF154?
Well, ZNF is short for zinc finger.
Apparently there is what any sane observer would regard as a ridiculous
number of ZNF genes. Each codes for a
protein that is characterized by finger-like protrusions containing a zinc
atom. These ZNF proteins perform a
variety of functions: ZNF154 is described as a “transcription factor”, which I
take to imply that it has something to do with “transcribing” the information on
DNA onto a messenger RNA molecule. In
the literature I read the downward spiral continued, but I was already thoroughly
drowned. I wish I had studied biochemistry.
As an aside, heretofore “zinc finger” molecules seem to have
been used to “edit” DNA, but this has been superseded by the CRISPR technique,
with which you are certainly familiar.
Also, the bottom of this article shifts direction and gives you
some details about current Moonshot planning.
I worry that it will merely involve more money. Cancer cannot be drowned in money. Joe Biden: for God’s sake, read my blogs!
Small world - I've been reading about tristetraprolin otherwise known as zinc finger protein 36 homolog (ZFP36). It may have some potential for modulating inflammation eg that of autoimmune disease, in addition to anticancer activity. Paper was in a recent NEJM issue - would you like me to send you the link?
ReplyDeleteYes, please.
DeleteWay more than you ever wanted to know about gene editing. But wait – I just read the whole damned thing and I’m not absolutely sure I learned anything important. This article tells you about the four current gene-editing techniques, hints at how they might be used – but tells you nothing about how they work. But, hell, I put in the time, so here’s the comment:
Deletehttp://www.fredhutch.org/en/news/center-news/2016/08/crispr-and-other-gene-editing-show-cure-potential.html